Crewe Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14
Closed -$126 754
2023
Q2
$126 Buy
+14
New +$126 ﹤0.01% 826